Hinge Health Inc. (NYSE:HNGE) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Hinge Health Inc. has received an average rating of "Moderate Buy" from analysts, with fifteen out of eighteen recommending a buy and one a strong buy.
• The average 1-year target price for the stock is approximately $57.13, reflecting optimism among brokers about its future performance.
• Shares of Hinge Health opened at $59.70, with a 1-year trading range between $33.42 and $62.18, indicating significant volatility in its stock price.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) has received an average recommendation of "Moderate Buy" from the eighteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $57.1333.

A number of brokerages recently issued reports on HNGE. William Blair began coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "outperform" rating on the stock. Wall Street Zen upgraded shares of Hinge Health to a "hold" rating in a research report on Monday, June 2nd. JMP Securities raised their target price on shares of Hinge Health from $58.00 to $65.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Baird R W raised shares of Hinge Health to a "hold" rating in a research note on Friday, September 5th. Finally, Barclays increased their price target on shares of Hinge Health from $51.00 to $62.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 6th.

Hedge Funds Weigh In On Hinge Health

A number of large investors have recently bought and sold shares of the stock. Montag A & Associates Inc. purchased a new position in Hinge Health during the second quarter worth approximately $41,000. SBI Securities Co. Ltd. purchased a new position in Hinge Health during the second quarter worth approximately $48,000. PNC Financial Services Group Inc. purchased a new position in Hinge Health during the second quarter worth approximately $71,000. Emerald Advisers LLC acquired a new stake in shares of Hinge Health in the second quarter worth $108,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in shares of Hinge Health in the 2nd quarter valued at $114,000.

Hinge Health Trading Up 3.2%

Shares of NYSE HNGE opened at $59.70 on Wednesday. Hinge Health has a 1 year low of $33.42 and a 1 year high of $62.18. The stock's 50 day moving average price is $53.95.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.